Kininase I-type carboxypeptidases enhance nitric oxide production in endothelial cells by generating bradykinin B1 receptor agonists

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 284, Issue 6 53-6, 2003, Pages

  Sangsree, Sakonwun ^a   Brovkovych, Viktor ^a   Minshall, Richard D ^a   Skidgel, Randal A ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Bradykinin B2 receptor; Carboxypeptidase D; Carboxypeptidase M; Interferon ; Interleukin 1

Indexed keywords

ARGININE CARBOXYPEPTIDASE; BRADYKININ; BRADYKININ B1 RECEPTOR AGONIST; BRADYKININ B2 RECEPTOR AGONIST; CARBOXYPEPTIDASE; CARBOXYPEPTIDASE D; CARBOXYPEPTIDASE M; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GAMMA INTERFERON; ICATIBANT; INTERLEUKIN 1BETA; KALLIDIN DERIVATIVE; KALLIDIN[1-9]; KALLIDIN[9 LEUCINE 10 DEARGININE]; NITRIC OXIDE; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LOCALIZATION; GOLGI COMPLEX; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUNG ENDOTHELIUM; MICROVASCULATURE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

EID: 0037686694     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00036.2003     Document Type: Article

References (60)

1. Agata J, Miao RQ, Yayama K, Chao L, and Chao J. Bradykinin B(1) receptor mediates inhibition of neointima formation in rat artery after balloon angioplasty. Hypertension 36: 364-370, 2000.
2. Austin CE, Faussner A, Robinson HE, Chakravarty S, Kyle DJ, Bathon JM, and Proud D. Stable expression of the human kinin B1 receptor in Chinese hamster ovary cells. Characterization of ligand binding and effector pathways. J Biol Chem 272: 11420-11425, 1997.
3. Bhoola KD, Figueroa CD, and Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev 44: 1-80, 1992.
4. Bouchard JF, Chouinard J, and Lamontagne D. Role of kinins in the endothelial protective effect of ischaemic preconditioning. Br J Pharmacol 123: 413-420, 1998.
5. Brovkovych V, Stolarczyk E, Oman J, Tomboulian P, and Malinski T. Direct electrochemical measurement of nitric oxide in vascular endothelium. J Pharm Biomed Anal 19: 135-143, 1999.
6. Chahine R, Adam A, Yamaguchi N, Gaspo R, Regoli D, and Nadeau R. Protective effects of bradykinin on the ischaemic heart: implication of the B1 receptor. Br J Pharmacol 108: 318-322, 1993.
7. Connelly L, Palacios-Callender M, Ameixa C, Moncada S, and Hobbs AJ. Biphasic regulation of NF-kappa B activity underlies the pro- and anti-inflammatory actions of nitric oxide. J Immunol 166: 3873-3881, 2001.
8. 2+ activation and inhibitor binding of carboxypeptidase M at low pH. Similarity to carboxypeptidase H (enkephalin convertase). Biochem J 261: 289-291, 1989.
9. Deddish PA, Skidgel RA, Kriho VB, Li XY, Becker RP, and Erdiis EG. Carboxypeptidase M in Madin-Darby canine kidney cells. Evidence that carboxypeptidase M has a phosphatidylinositol glycan anchor. J Biol Chem 265: 15083-15089, 1990.
10. 1 MF-2 smooth muscle cells. J Biol Chem 272: 17858-17866, 1997.
11. Erdös EG. Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K Dahl memorial lecture. Hypertension 16: 363-370, 1990.
12. Erdös EG (Editor). Kininases. In: Handbook of Experimental Pharmacology. Heidelberg: Springer-Verlag, 1979, p. 427-487.
13. Erdös EG. Kinins, the long march-a personal view. Cardiovasc Res 54: 485-491, 2002.
14. Erdös EG, Deddish PA, and Marcic BM. Potentiation of bradykinin actions by ACE inhibitors. Trends Endocrinol Metab 10: 223-229, 1999.
15. Erdös EG and Marcic BM. Kinins, receptors, kininases and inhibitors-where did they lead us? Biol Chem 382: 43-47, 2001.
16. Erdös EG and Sloane EM. An enzyme in human blood plasma that inactivates bradykinin and kallidins. Biochem Pharmacol 11: 582-592, 1962.
17. Fricker LD. Carboxypeptidase E. Annu Rev Physiol 50: 309- 321, 1988.
18. Fricker LD and Snyder SH. Purification and characterization of enkephalin convertase, an enkephalin-synthesizing carboxypeptidase. J Biol Chem 258: 10950-10955, 1983.
19. Hadkar V and Skidgel RA. Carboxypeptidase D is upregulated in RAW 264.7 macrophages and stimulates nitric oxide synthesis by cells in arginine-free medium. Mol Pharmacol 59: 1324-1332, 2001.
20. Hobbs AJ, Higgs A, and Moncada S. Inhibition of nitric oxide synthase as a potential therapeutic target. Annu Rev Pharmacol Toxicol 39: 191-220, 1999.
21. Ignjatovic T, Tan F, Brovkovych V, Skidgel RA, and Erdos EG. Novel mode of action of angiotensin I converting enzyme inhibitors: direct activation of bradykinin B1 receptor. J Biol Chem 277: 16847-16852, 2002.
22. Ischiropoulos H, Zhu L, and Beckman JS. Peroxynitrite formation from macrophage-derived nitric oxide. Arch Biochem Biophys 298: 446-451, 1992.
23. Kirkeboen KA and Strand OA. The role of nitric oxide in sepsis-an overview. Acta Anaesthesiol Scand 43: 275-288, 1999.
24. Kubes P. Nitric oxide affects microvascular permeability in the intact and inflamed vasculature. Microcirculation 2: 235-244, 1995.
25. Kuroki K, Cheung R, Marion PL, and Ganem D. A cell surface protein that binds avian hepatitis B virus particles. J Virol 68: 2091-2096, 1994.
26. Kuroki K, Eng F, Ishikawa T, Turck C, Harada F, and Ganem D. gp18O, a host cell glycoprotein that binds duck hepatitis B virus particles, is encoded by a member of the carboxypeptidase gene family. J Biol Chem 270: 15022-15028, 1995.
27. Lamb ME, De Weerd WF, and Leeb-Lundberg LM. Agonist-promoted trafficking of human bradykinin receptors: arrestin- and dynamin-independent sequestration of the B2 receptor and bradykinin in HEK293 cells. Biochem J 355: 741-750, 2001.
28. Linz W, Wiemer G, Gohlke P, Unger T, and Schölkens BA. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev 47: 25-49, 1995.
29. Loscalzo J and Welch G. Nitric oxide and its role in the cardiovascular system. Prog Cardiovasc Dis 38: 87-104, 1995.
30. Malinski T and Taha Z. Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor. Nature 358: 676-678, 1992.
31. 1 receptors for kinins. Pharmacol Rev 50: 357-386, 1998.
32. 1-receptors in normotensive rats and mice under chronic Angiotensin-converting enzyme inhibitor treatment. Circulation 105: 627-632, 2002.
33. McGwire GB and Skidgel RA. Extracellular conversion of epidermal growth factor (EGF) to des-Arg53-EGF by carboxypeptidase M. J Biol Chem 270: 17154-17158, 1995.
34. McGwire GB, Tan F, Michel B, Rehli M, and Skidgel RA. Identification of a membrane-bound carboxypeptidase as the mammalian homolog of duck gp180, a hepatitis B virus-binding protein. Life Sci 60: 715-724, 1997.
35. 141 from the a chain of human hemoglobin by carboxypeptidase N and M. Circ Res 78: 635-642, 1996.
36. Moncada S, Palmer RM, and Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142, 1991.
37. Nagae A, Deddish PA, Becker RP, Anderson CH, Abe M, Tan F, Skidgel RA, and Erdös EG. Carboxypeptidase M in brain and peripheral nerves. J Neurochem 59: 2201-2212, 1992.
38. Palmer RM, Ashton DS, and Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333: 664-666, 1988.
39. Regoli D and Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol Rev 32: 1-46, 1980.
40. Reznik SE and Fricker LD. Carboxypeptidases from A to Z: implications in embryonic development and Wnt binding. Cell Mol Life Sci 58: 1790-1804, 2001.
41. Skidgel RA. Assays for arginine/lysine carboxypeptidases: Carboxypeptidase H (E; enkephalin convertase), M and N. In: Methods in Neurosciences: Peptide Technology, edited by Conn PM. Orlando: Academic, 1991, p. 373-385.
42. Skidgel RA. Basic carboxypeptidases: regulators of peptide hormone activity. Trends Pharmacol Sci 9: 299-304, 1988.
43. Skidgel RA. Proliferation of regulatory mechanisms for eNOS: an emerging role for the cytoskeleton. Am J Physiol Lung Cell Mol Physiol 282: L1179-L1182, 2002.
44. Skidgel RA. Structure and function of mammalian zinc carboxypeptidases. In: Zinc Metalloproteases in Health and Disease, edited by Hooper NM. London: Taylor and Francis, 1996, p. 241-283.
45. Skidgel RA, Davis RM, and Tan F. Human carboxypeptidase M. Purification and characterization of a membrane-bound carboxypeptidase that cleaves peptide hormones. J Biol Chem 264: 2236-2241, 1989.
46. Skidgel RA and Erdös EG. Cellular carboxypeptidases. Immunol Rev 161: 129-141, 1998.
47. Skidgel RA and Erdös EG. Enzymatic breakdown of bradykinin. In: Pro-inflammatory and Anti-inflammatory Peptides, edited by Said SI. New York: Marcel-Dekker, 1998, p. 459-476.
48. Skidgel RA, Johnson AR, and Erdös EG. Hydrolysis of opioid hexapeptides by carboxypeptidase N. Presence of carboxypeptidase in cell membranes. Biochem Pharmacol 33: 3471-3478, 1984.
49. Skidgel RA, Tan F, Deddish PA, and Li XY. Structure, function and membrane anchoring of carboxypeptidase M. Biomed Biochim Acta 50: 815-820, 1991.
50. 2 bradykinin receptors in bovine pulmonary artery endothelial cells. Mol Pharmacol 47: 525-534, 1995.
51. Song L and Fricker LD. Purification and characterization of carboxypeptidase D, a novel carboxypeptidase E-like enzyme, from bovine pituitary. J Biol Chem 270: 25007-25013 1995.
52. Spangenberg HC, Lee HB, Li J, Tan F, Skidgel R, Wands JR, and Tong S. A short sequence within domain C of duck carboxypeptidase D is critical for duck hepatitis B virus binding and determines host specificity. J Virol 75: 10630-10642, 2001.
53. Tan F, Deddish PA, and Skidgel RA. Human carboxypeptidase M. Methods Enzymol 248: 663-675, 1995.
54. Tan F, Rehli M, Krause SW, and Skidgel RA. Sequence of human carboxypeptidase D reveals it to be a member of the regulatory carboxypeptidase family with three tandem active site domains. Biochem J 327: 81-87, 1997.
55. Timblin B, Rehli M, and Skidgel RA. Structural characterization of the human carboxypeptidase D gene and its promoter. Int Immunopharmacol 2: 1907-1917, 2002.
56. Tsao PS, Wang B, Buitrago R, Shyy JY, and Cooke JP. Nitric oxide regulates monocyte chemotactic protein-1 Circulation 96: 934-940, 1997.
57. Varlamov O and Fricker LD. Intracellular trafficking of metallocarboxypeptidase D in AtT-20 cells: localization to the transGolgi network and recycling from the cell surface. J Cell Sci 111: 877-885, 1998.
58. Wolkow PP. Involvement and dual effects of nitric oxide in septic shock. Inflamm Res 47: 152-166, 1998.
59. Xie QW, Kashiwabara Y, and Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 269: 4705-4708, 1994.
60. Xin X, Varlamov O, Day R, Dong W, Bridgett MM, Leiter EH, and Fricker LD. Cloning and sequence analysis of cDNA encoding rat carboxypeptidase D. DNA Cell Biol 16: 897-909, 1997.